A systematic review of cost-utility analyses of screening methods in latent tuberculosis infection in high-risk populations
Abstract Background The World Health Organisation (WHO) recommends that testing and treatment for latent tuberculosis infection (LTBI) should be undertaken in high-risk groups using either interferon gamma release assays (IGRAs) or a tuberculin skin test (TST). As IGRAs are more expensive than TST,...
Κύριοι συγγραφείς: | , , , , , , , , , , |
---|---|
Μορφή: | Άρθρο |
Γλώσσα: | English |
Έκδοση: |
BMC
2022-10-01
|
Σειρά: | BMC Pulmonary Medicine |
Θέματα: | |
Διαθέσιμο Online: | https://doi.org/10.1186/s12890-022-02149-x |